MRK

Merck & Co., Inc.

HealthcareDrug Manufacturers - GeneralUSUSDPeers →

$120.79

LiveJun 05, 2026

AI Brief

Market cap

$298.33B

52w range

76.66 – 125.14

P / E

—

EPS · FY 2025

$7.28

Volume

8.86M

Revenue · FY 2025

$64.93B

+1.18% YoY

Overview Profile Financials Ratios Multiples Valuation Factors Quant Themes Trend Thesis Committee Earnings Segments Prices Analysts Dividends Corp actions Insiders Sentiment ESG

Explain this page

Arphra AIPlain-English read on Merck & Co., Inc.’s valuation

Splits to date

last · 131:125 Jun 2021

Cumulative split

226:1

across recorded splits

Dividend events

15 raises

Corporate actions

· stock_splits · dividends

most recent first

Dec 2025Dividend raisedividend
+5% — $0.81 → $0.85
Dec 2024Dividend raisedividend
+5% — $0.77 → $0.81
Dec 2023Dividend raisedividend
+5% — $0.73 → $0.77
Dec 2022Dividend raisedividend
+6% — $0.69 → $0.73
Dec 2021Dividend raisedividend
+6% — $0.65 → $0.69
Jun 2021Stock splitsplit
131-for-125 forward split
Dec 2020Dividend raisedividend
+7% — $0.61 → $0.65
Dec 2019Dividend raisedividend
+11% — $0.55 → $0.61
Dec 2018Dividend raisedividend
+15% — $0.48 → $0.55
Dec 2017Dividend raisedividend
+2% — $0.47 → $0.48
Dec 2016Dividend raisedividend
+2% — $0.46 → $0.47
Dec 2015Dividend raisedividend
+2% — $0.45 → $0.46
Dec 2014Dividend raisedividend
+2% — $0.44 → $0.45
Dec 2013Dividend raisedividend
+2% — $0.43 → $0.44

Stock splits

DB · stock_splits7

Date	Ratio	Type	Multiplier
Jun 03, 2021	131-for-125	Forward	1.05×
Feb 17, 1999	2-for-1	Forward	2.00×
May 26, 1992	3-for-1	Forward	3.00×
May 26, 1988	3-for-1	Forward	3.00×
May 27, 1986	2-for-1	Forward	2.00×
Jun 01, 1972	2-for-1	Forward	2.00×
May 27, 1964	3-for-1	Forward	3.00×

M&A activity

1DB

Whole-company transactions where MRK is acquirer or target.

Date	Role	Counterparty	Filing
Dec 18, 1995	Acquirer	Schering	SEC →

Beneficial-ownership filings

DB · 13D/G50

Filed	Form	Reporter	% owned	Shares
Apr 30, 2026	—	Vanguard Capital Management	7.53%	—	SEC →
Mar 27, 2026	—	The Vanguard Group	0.00%	—	SEC →
Mar 06, 2025	—	The Vanguard Group	10.02%	—	SEC →
Feb 03, 2025	—	Merck & Co., Inc.	19.96%	—	SEC →
Jan 23, 2024	—	Merck Global Health Innovation Fund, LLC	11.40%	—	SEC →
Jan 23, 2024	—	Merck Sharp & Dohme LLC	11.40%	—	SEC →
Jan 23, 2024	—	Merck & Co., Inc.	11.40%	—	SEC →
Feb 02, 2022	—	Merck Sharp & Dohme Corp.	6.60%	—	SEC →
Feb 02, 2022	—	Merck & Co., Inc.	6.60%	—	SEC →
Feb 01, 2022	—	(1) BlackRock, Inc.	7.80%	—	SEC →
Mar 04, 2021	—	MERCK & CO., INC.	39.99%	—	SEC →
Mar 04, 2021	—	MERCK SHARP & DOHME CORP.	39.99%	—	SEC →
Mar 04, 2021	—	PANAMA MERGER SUB, INC.	39.99%	—	SEC →
Jan 04, 2021	—	Merck Sharp & Dohme Corp.	5.20%	—	SEC →
Jan 04, 2021	—	Merck & Co., Inc.	5.20%	—	SEC →
Feb 12, 2020	—	The Vanguard Group - 23-1945930	8.26%	—	SEC →
Dec 16, 2019	—	MERCK SHARP & DOHME CORP.	12.60%	—	SEC →
Dec 16, 2019	—	MERCK & CO., INC.	12.60%	—	SEC →
Dec 16, 2019	—	ARGON MERGER SUB, INC.	12.60%	—	SEC →
Apr 09, 2019	—	Merck & Co., Inc.	19.90%	—	SEC →
Apr 09, 2019	—	Merck Sharp & Dohme Corp.	19.90%	—	SEC →
Feb 14, 2019	—	Merck Sharp & Dohme Corp.	5.10%	—	SEC →
Feb 14, 2019	—	MRL Ventures Fund LLC	5.10%	—	SEC →
Feb 14, 2019	—	Merck & Co., Inc.	5.10%	—	SEC →
Feb 06, 2019	—	(1) BlackRock, Inc.	7.50%	—	SEC →
Oct 04, 2018	—	Merck & Co., Inc.	11.90%	—	SEC →
Oct 04, 2018	—	Merck Sharp & Dohme Corp.	11.90%	—	SEC →
Feb 14, 2018	—	Merck & Co., Inc.	5.41%	—	SEC →
Feb 14, 2018	—	Merck Sharp & Dohme Corp.	5.41%	—	SEC →
Feb 13, 2018	—	Merck Sharp & Dohme Research GmbH	0.00%	—	SEC →
Feb 13, 2018	—	Merck Sharp & Dohme Corp.	0.00%	—	SEC →
Feb 13, 2018	—	Merck & Co., Inc.	0.00%	—	SEC →
Nov 15, 2017	—	Merck Sharp & Dohme Corp.	6.50%	—	SEC →
Nov 15, 2017	—	MRL Ventures Fund LLC	6.50%	—	SEC →
Nov 15, 2017	—	Merck & Co., Inc.	6.50%	—	SEC →
Oct 16, 2017	—	1,070,589 shares	9.90%	—	SEC →
Oct 16, 2017	—	9.9%*	9.90%	—	SEC →
Feb 09, 2017	—	Wellington Management Group LLP	4.50%	—	SEC →
Feb 09, 2017	—	Wellington Group Holdings LLP	4.50%	—	SEC →
Feb 09, 2017	—	Wellington Investment Advisors Holdings LLP	4.50%	—	SEC →
Feb 12, 2016	—	Inc.	7.40%	—	SEC →
Feb 12, 2016	—	Merck Sharp & Dohme Corp.	7.40%	—	SEC →
Feb 12, 2016	—	Merck Sharp & Dohme Research GmbH	7.40%	—	SEC →
Feb 11, 2015	—	Vanguard Group - 23-1945930	5.46%	—	SEC →
Feb 09, 2015	—	(1) BlackRock, Inc.	6.60%	—	SEC →
Jun 13, 2014	—	MERCK & CO., INC.	14.90%	—	SEC →
Jun 13, 2014	—	IMPERIAL BLUE CORPORATION	14.90%	—	SEC →
Feb 14, 2014	—	04-2683227	5.27%	—	SEC →
Apr 15, 2011	—	22-1918501	27.50%	—	SEC →
Apr 15, 2011	—	45-1540007	27.50%	—	SEC →

Corporate actions combine splits (live, full history), symbol changes (refreshed weekly), the daily M&A wire, and 13D/G filings.